Who has invested in Abata Therapeutics?

Third Rock Ventures are named among the investors backing Abata Therapeutics.

Abata Therapeutics Funding: $95M Raised, Seed (2021)

Abata Therapeutics funding overview

Abata Therapeutics has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in June 2021. The round record for Abata Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Third Rock Ventures.

Abata Therapeutics at a glance

Total raised: $95M
Latest round: Seed
Latest round date: June 2021
Notable investors: Third Rock Ventures

Frequently asked about Abata Therapeutics funding

How much has Abata Therapeutics raised?: Abata Therapeutics has raised $95M in total disclosed funding across the rounds on record.
Who has invested in Abata Therapeutics?: Third Rock Ventures are named among the investors backing Abata Therapeutics.
What was the latest Abata Therapeutics funding round?: The most recent disclosed round is a Seed, announced in June 2021.
Where is Abata Therapeutics based?: No headquarters location is disclosed for Abata Therapeutics.
When did Abata Therapeutics last raise?: The last disclosed Abata Therapeutics round closed in June 2021 at Seed.

We update the Abata Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.

Abata Therapeutics Funding: $95M Raised, Seed (2021)

Abata Therapeutics funding overview

Abata Therapeutics at a glance

Frequently asked about Abata Therapeutics funding

Companies related to Abata Therapeutics (18)

Browse related funding lists (4)